BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balassy C, Roberts D, Miller SF. Safety and efficacy of gadoteric acid in pediatric magnetic resonance imaging: overview of clinical trials and post-marketing studies. Pediatr Radiol 2015;45:1831-41. [PMID: 26045036 DOI: 10.1007/s00247-015-3394-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Chang DH, Pracros JP. Safety of gadoterate meglumine in over 1600 children included in the prospective observational SECURE study. Acta Radiol 2019;60:1450-6. [PMID: 31027425 DOI: 10.1177/0284185119840649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Roberts DR, Chatterjee AR. The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body. Invest Radiol 2019;54:72-5. [PMID: 30273280 DOI: 10.1097/RLI.0000000000000516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Scala M, Koob M, de Buttet S, Bourrinet P, Felices M, Jurkiewicz E. A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years. Invest Radiol 2018;53:70-9. [PMID: 28906338 DOI: 10.1097/RLI.0000000000000412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Blumfield E, Swenson DW, Iyer RS, Stanescu AL. Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients. Pediatr Radiol 2019;49:448-57. [PMID: 30923876 DOI: 10.1007/s00247-018-4304-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
5 Tamrazi B, Nguyen B, Liu CJ, Azen CG, Nelson MB, Dhall G, Nelson MD. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration. Radiology 2018;287:452-60. [PMID: 29189102 DOI: 10.1148/radiol.2017171850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
6 Soyer P, Dohan A, Patkar D, Gottschalk A. Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study. J Magn Reson Imaging. 2017;45:988-997. [PMID: 27726239 DOI: 10.1002/jmri.25486] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
7 Braun J, Busse R, Darmon-Kern E, Heine O, Auer J, Meyl T, Maurer M, Hamm B, de Bucourt M. Baseline characteristics, diagnostic efficacy, and peri-examinational safety of IV gadoteric acid MRI in 148,489 patients. Acta Radiol 2020;61:910-20. [PMID: 31739672 DOI: 10.1177/0284185119883390] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Farmakis SG, Hardy AK, Mahmoud SY, Wilson-Flewelling SA, Tao TY. Safety of gadoterate meglumine in children younger than 2 years of age. Pediatr Radiol 2020;50:855-62. [PMID: 32055917 DOI: 10.1007/s00247-020-04626-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Roberts DR, Chatterjee AR, Yazdani M, Marebwa B, Brown T, Collins H, Bolles G, Jenrette JM, Nietert PJ, Zhu X. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol 2016;37:2340-7. [PMID: 27469211 DOI: 10.3174/ajnr.A4891] [Cited by in Crossref: 82] [Cited by in F6Publishing: 32] [Article Influence: 13.7] [Reference Citation Analysis]
10 Moon WJ, Cho YA, Hahn S, Son HM, Woo SK, Lee YH. The Pattern of Use, Effectiveness, and Safety of Gadoteric Acid (Clariscan) in Patients Undergoing Contrast-Enhanced Magnetic Resonance Imaging: A Prospective, Multicenter, Observational Study. Contrast Media Mol Imaging 2021;2021:4764348. [PMID: 34803545 DOI: 10.1155/2021/4764348] [Reference Citation Analysis]
11 Alfano G, Fontana F, Ferrari A, Solazzo A, Perrone R, Giaroni F, Torricelli P, Cappelli G. Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment. Magn Reson Imaging 2020;70:1-4. [PMID: 32112811 DOI: 10.1016/j.mri.2020.02.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Turk O, Ozdemir NG, Atci IB, Saygi T, Yilmaz H, Antar V. Intraventricular Gadoteric Acid Intoxication: First Report. World Neurosurg 2018;111:264-8. [PMID: 29292188 DOI: 10.1016/j.wneu.2017.12.130] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]